A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

The American Academy of Orthopaedic Surgeons June 22, 2020 Statement

The American Academy of Orthopaedic Surgeons’ (AAOS, Academy) history regarding actively addressing diversity, inclusion, and discrimination have been abysmal. Based on the Academy’s lack of material and substantive actions to support its diverse members, despite unfulfilled, public statements and documented strategies, this open letter serves as a vote of no confidence in the leadership of the AAOS from the Concerned Faces of Orthopaedics (CFOO), a group of board-certified orthopaedic surgeons.

In May of 2020, in a statement written in part as a response to widely circulated videos depicting the horrific murders of Ahmaud Arbery and George Floyd by past and present members of law enforcement, the current president of the AAOS, Joseph Bosco, MD, indicated that the Academy “stands” with its members of color and that “…although words are important, deeds matter most.” From the standpoint of the CFOO, the AAOS deeds have been the antithesis of this statement, as evidenced by:

  • The defunding and removal of the specialty societies that represent diverse orthopaedic surgeons from its administrative umbrella, namely the J. Robert Gladden Orthopaedic Society, the Ruth Jackson Orthopaedic Society and the American Association of Latino Orthopaedic Surgeons
  • Demotion of the Diversity Advisory Board to a committee that no longer has direct responsibilities to act nor report to the board on matters regarding diversity, equity, and inclusion
  • Zero annual resource allocation of successful pipeline programs for underrepresented in medicine students and women with zero dollars from the AAOS budget
  • Recent election of an overwhelmingly white, all-male AAOS Nominating Committee, which is responsible for guiding the selection process of the presidential line and determining the at-large membership of the Board of Directors

In the context of the recent past and present actions of the AAOS, it is difficult to have faith in the words submitted by its current leadership. James Baldwin, noted American novelist, essayist and activist once said, “I can’t believe what you say, because I see what you do.”

Moving forward, only definitive and actionable steps will be acceptable, as the aforementioned requirements represent the floor for the continuous work of transforming the AAOS into a more inclusive and equitable body.

Continued refusal of the AAOS to satisfactorily address these concerns undermines our ability to achieve health equity for our patients and for AAOS members, but it also undermines the success of the body as a whole. Continued inaction also requires its most affected members to use whatever means necessary to amplify our concerns through mainstream and social media sources. The Concerned Faces of Orthopaedics looks forward to a response from the Academy.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy